Clinical Trial Update: A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral decitabine/cedazuridine with azacitidine in myelodysplastic syndromes, acute myeloid leukemia with low blast counts, and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Oral Decitabine/Cedazuridine (decitabine/cedazuridine)

Snippet

Sponsor: Otsuka Australia Pharmaceutical Pty Ltd | Conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | Phase 3 | Status: ACTIVE_NOT_RECRUITING